otrzewnową Hypotonia during amikacine administration in a patient treated with continuous ambulatory peritoneal dialysis

The prevalence of hypotonia in patients on continuous ambulatory peritoneal dialysis (CADO) is about 12%, and its pathophysiology is complex. The study presents a case of a patient on CADO, whose episodes of low blood pressure may be associated with the use of antibiotic amikacine (group of aminoglycosides). Female, aged 68, was admitted to the Clinic for CADO treatment of the renal failure. In the first week after the catheter implantation the patient complained of dysuric symptoms. Due to significant E. coli bacteriuria 250 mg amikacine and 1 g cefazolin was introduced according to antibiogram. In the third day of antibioticotherapy the patient fainted with the blood pressure of 90/60 mm Hg. In the following days the patient presented blood pressure falls to the values of 90/60–80/50 mm Hg 2or 3-times a day. The patient was feeling ill. All anti-hypertensives were stopped. In the repeated urinalysis leukocyturia was not found. Two days following the cessation of antibiotics patient’s state improved and the episodes of hypotonia disappeared. Blood pressure values increased and amlodipine and perindopril treatment was introduced in previously used doses. The mechanism of the hypotensive effect of aminoglycosides remains unclear. One of the hypotheses assumes that aminoglycosides are Maria Wanic-Kossowska, Alicja Grzegorzewska, Anna Posadzy-Małaczyńska, Andrzej Tykarski, Mikołaj Kobelski, Paweł Bączyk, Lidia Kozioł, Stanisław Czekalski

[1]  K. Drewnowska,et al.  Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. , 2005, American journal of hypertension.

[2]  C. Benishin,et al.  Regulation of parathyroid hypertensive factor secretion by Ca2+ in spontaneously hypertensive rat parathyroid cells. , 2004, American journal of hypertension.

[3]  S. Miedlich,et al.  Calcium sensing receptors as integrators of multiple metabolic signals. , 2004, Cell calcium.

[4]  D. Ward,et al.  Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. , 2002, Biochemical and biophysical research communications.

[5]  A. Cases,et al.  Chronic hypotension in the dialysis patient. , 2002, Journal of nephrology.

[6]  D. Ward,et al.  Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. , 2002, Journal of the American Society of Nephrology : JASN.

[7]  W. Liu,et al.  A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. , 2000, Kidney international.

[8]  G. Laurent,et al.  Apoptosis in Renal Proximal Tubules of Rats Treated with Low Doses of Aminoglycosides , 2000, Antimicrobial Agents and Chemotherapy.

[9]  R. Lewanczuk,et al.  Parathyroid hypertensive factor secretion from subcultured spontaneously hypertensive rat parathyroid cells. , 1999, American journal of hypertension.

[10]  D. Oreopoulos,et al.  Hypotension on continuous ambulatory peritoneal dialysis. , 1996, Clinical nephrology.

[11]  Jing Shan,et al.  Purification and Structural Characterization of Parathyroid Hypertensive Factor , 1994, Journal of cardiovascular pharmacology.

[12]  Jing Shan,et al.  PHF: the new parathyroid hypertensive factor. , 1994, Blood pressure.

[13]  I. Biaggioni,et al.  Chronic hypotension. In the shadow of hypertension. , 1992, American journal of hypertension.

[14]  Marek Sznajderman,et al.  Niskie ciśnienie krwi - norma czy choroba? , 2003 .

[15]  J. Bargman,et al.  Hypotension in patients on chronic peritoneal dialysis: etiology, management, and outcome. , 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[16]  K. Kisters,et al.  Increased membraneous calcium concentrations in primary hypertension: a causal link to pathogenesis? , 2001, Journal of Human Hypertension.

[17]  K. Hyde,et al.  Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  M. Hagiwara,et al.  Inhibitory effects of aminoglycosides on renal protein phosphorylation by protein kinase C. , 1988, The Journal of pharmacology and experimental therapeutics.